# VibrantX

An AI-driven macromolecule drug developer

VibrantX develops AI-driven macromolecule drugs.

Canonical: https://uniquebase.ai/companies/xinhuashengwu
Stable identifier: UB-C3501
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-16T01:13:26.782Z

## Funding

Listed 2 records.
Latest: RMB 100M (Pre-Series A), 2022-01-13.

- 2025-08-25 · Tens of millions of US dollars · Series A · Hongshan China, 三一创新投资, 杏泽资本
- 2022-01-13 · RMB 100M (≈ $14.3M) · Pre-Series A · Hongshan China, 丹麓资本, 经纬创投

## Valuation

Listed 2 records.

- 2025-08-25 · amount unavailable · Series A · Hongshan China, 三一创新投资, 杏泽资本
- 2022-01-13 · amount unavailable · Pre-Series A · Hongshan China, 丹麓资本, 经纬创投

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

- [Xinhua Biotechnology](/products/xinhuashengwu)

## Investors

- [Hongshan China](/institutions/hongshan-china)
- [三一创新投资](/institutions/sanyi-innovation-investment)
- [丹麓资本](/institutions/danlu-capital)
- [杏泽资本](/institutions/xingze-capital)
- [经纬创投](/institutions/jingwei-venture-capital)

## Sources

- No source links are available for this profile.